Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 74Colorectal Neoplasms 41Central Nervous System Neoplasms 37Colonic Neoplasms 36Rectal Neoplasms 34Glioblastoma 23Carcinoma, Non-Small-Cell Lung 21Gliosarcoma 20Stomach Neoplasms 18Lung Neoplasms 18Pancreatic Neoplasms 16Head and Neck Neoplasms 16Sarcoma 14Ovarian Neoplasms 14Squamous Cell Carcinoma of Head and Neck 13Prostatic Neoplasms 12Neoplasm Metastasis 11Melanoma 11Esophageal Neoplasms 11Carcinoma, Ovarian Epithelial 11Carcinoma, Intraductal, Noninfiltrating 11Astrocytoma 11Fallopian Tube Neoplasms 10Brain Neoplasms 10Uterine Cervical Neoplasms 9Kidney Neoplasms 9Breast Carcinoma In Situ 9Liver Neoplasms 8Breast Neoplasms, Male 8Adenocarcinoma Of Esophagus 8

Interventions

Pemetrexed 14Carboplatin 13osimertinib 11aflutinib 9Drug Therapy 9Gefitinib 8Radiotherapy 6Docetaxel 6Cisplatin 6pembrolizumab 5anlotinib 5Radiosurgery 5Paclitaxel 5icotinib 4Vinorelbine 4Gemcitabine 4Erlotinib Hydrochloride 4tislelizumab 3camrelizumab 3apatinib 3HM781-36B 3toripalimab 2spartalizumab 2rezivertinib 2dacomitinib 2Tyrosine Kinase Inhibitors 2Thalidomide 2Surgical Procedures, Operative 2S 1 (combination) 2Platinum 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NSCLC × Chemotherapy, Adjuvant × Clear all
NCT07089199 2025-07-28

TitAN

Qilu Hospital of Shandong University

Phase 2 Not yet recruiting
34 enrolled
Thoracic

NSCLC

NCT05286957 2023-03-17

Seagull

The First Affiliated Hospital of Zhengzhou University

Phase 2 Recruiting
60 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡